AARP fights high drug prices on behalf of members

Wall Street Journal

 2 September 2019 - AARP is fighting for change: So far this year, there are 35 new laws across 23 states to help reduce drug costs.

Dr. Gerard Gianoli’s “AARP’s Interests Diverge From Its Members’” doesn’t address the root cause of skyrocketing drug prices: list prices set by Big Pharma itself. Pharma fuels attacks on AARP and other change-makers because it’s good for their business.

Quashing change hurts seniors, everyone who pays into health insurance, and taxpayers—since we all bear the costs of today’s out-of-control drug prices through premiums, cost-sharing and higher taxes.

Read Wall Street Journal article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing